Energy heavyweights are creating waves today as one posted solid Q1 earnings while another saw a profit dip. Meanwhile, a logistics tech firm is up 230% after adopting a Trump-themed meme coin as a reserve asset. Read on to find out more.
Bitcoin’s ups and downs have made and lost fortunes. But what if there was a way to outperform BTC—without ever buying it?
Hedge fund titan Larry Benedict has revealed a new approach called "Bitcoin Skimming," a strategy that has outpaced Bitcoin’s returns by as much as 22-to-1.
With the SEC’s latest decision set to shake up crypto markets, now is the perfect time to discover how this works.
Earnings:
None Listed
Economic Reports:
U.S. nonfarm payrolls [April]: 8:30 AM
U.S. unemployment rate [April]: 8:30 AM
U.S. hourly wages [April]: 8:30 AM
Factory orders [March]: 10:00 AM
Every investor in America is trying to figure out what Musk will do in Washington, D.C., in the coming weeks.
One Boston-based think tank – who has studied Elon’s work for decades – is stepping forward to share what they’ve found.
They believe his TRUE plan is far more radical than anyone realizes. It could change the way you live, work, get paid, and collect Social Security…
Exxon Mobil (NYSE: XOM) reported stronger-than-expected earnings for the first quarter, powered by rising output in Guyana and the Permian Basin, even as revenue stayed flat and refining margins shrank.
The oil giant posted a net income of $7.71 billion, or $1.76 per share—down from $8.22 billion, or $2.06 per share, a year earlier.
Still, the figure edged out Q4 2024 earnings and beat Wall Street estimates. Quarterly revenue was unchanged year-over-year at $83.1 billion.
A key bright spot was oil and gas production, which climbed to 4.55 million barrels of oil equivalent per day from 3.78 million last year.
Upstream earnings jumped 19% to $6.75 billion, driven by cost efficiencies and volume growth from strategically advantaged regions like Guyana and the Permian.
However, other business segments struggled. Refining profits slid nearly 40% to $827 million due to weaker market margins.
Chemical and specialty products also saw steep declines, with chemical earnings plunging 65% and specialty down nearly 14%, both hurt by lower sales volumes, higher costs, and foreign exchange headwinds.
Despite the profit dip, Exxon returned $9.1 billion to shareholders through dividends and stock buybacks and reaffirmed its $20 billion repurchase plan for the year.
Shares are up nearly 0.5% in pre-market trading following the release.
Shell (NYSE: SHEL) delivered better-than-expected profit for the first quarter of 2025 and confirmed that it will continue returning capital to investors at a steady pace, even as oil prices and refining margins declined.
The company reported adjusted earnings of $5.58 billion, surpassing analyst projections of $4.96 billion but falling short of last year’s $7.73 billion.
The decline was largely attributed to softer oil prices—averaging $75 per barrel this quarter versus $87 a year earlier—and reduced refining profits.
Shell plans to repurchase $3.5 billion worth of shares over the next three months, marking its 14th straight quarter with buybacks of at least $3 billion.
This approach contrasts sharply with competitor BP (BP.L), which scaled back its buyback program amid investor pressure to bolster its balance sheet.
The company’s gearing ratio stands at 18.7%, lower than BP’s 25.7%, giving it more financial flexibility.
Executives expressed confidence in the current share price being undervalued and emphasized strategic capital deployment.
Shell also reiterated its reduced capital spending target of $20–$22 billion for the year and said it remains on track with LNG trading growth.
The gas trading division performed steadily, benefiting from favorable cargo routing and strong execution—outpacing BP, which reported a weaker showing in this area.
Shares of Shell are up 2.6% in early trading, outperforming broader energy markets.
On Behalf of Azincourt Energy Corp
Uranium has doubled since 2020.
Saskatchewan’s uranium sales just hit $2.6 billion, up 62% year-over-year.
Cameco says the long-term outlook has never been stronger.
Now layer on the global demand curve:
30+ countries pledging to triple nuclear capacity
AI data centers expected to use 12% of US electricity by 2028
Germany reversing course and returning to nuclear
The setup is here.
And one company has plans to drill in the heart of it all: Canada’s Athabasca Basin.
With early uranium hits, expanding alteration zones, and proximity to NexGen and Cameco, this could be the next name to watch in the sector.
*Examples that we provide of share price increases pertaining to a particular Issuer from one referenced date to another represent an arbitrarily chosen time period and are no indication whatsoever of future stock prices for that Issuer and are of no predictive value. Our stock profiles are intended to highlight certain companies for YOUR further investigation; they are NOT stock recommendations or constitute an offer or sale of the referenced securities.
Chevron (NYSE: CVX) shares are down in premarket trading today after the energy giant reported a sharp profit decline for the first quarter, tied to falling oil prices and shrinking margins.
The company posted net income of $3.5 billion, or $2.00 per share, down over 30% from $5.5 billion, or $2.97 per share, a year earlier.
On an adjusted basis, earnings per share came in at $2.18, matching analyst expectations. Revenue also missed forecasts, coming in at $47.61 billion versus the projected $48.09 billion.
Weaker oil prices—down about 18% so far this year amid renewed tariff concerns under President Donald Trump and increased output from OPEC+—weighed heavily on Chevron’s results.
The company’s U.S. upstream operations brought in $1.86 billion in profit, down from $2.08 billion a year ago due to higher costs and lower commodity prices.
In response to the market environment, Chevron plans to reduce its share repurchases to $2.5–$3 billion in Q2, a notable drop from $3.9 billion in Q1.
Its refining segment turned profitable with $103 million after ending last quarter in the red, but earnings were still down 77% year-over-year. Daily production held steady at 3.35 million barrels, while capital spending slipped 5% to $3.9 billion.
The stock is down more than 2% in premarket trading following the report.
Freight Technologies, Inc., is a logistics management innovation company offering a suite of AI-powered platforms. Its gross margins were up to 9.8% in 2024 from 7.9% in 2023, and despite declining revenues, the firm was able to improve on its net loss.
It has nearly tripled itself this morning after it announced that it will raise $20M to adopt the Official Trump meme coin as a treasury reserve asset, becoming the first public company to do so.
My Take: The move seems to be aimed at counteracting the tariffs on Mexican and Canadian imports, an area where FRGT is involved in cross-border shipping. It’s a smart move, but the stock’s downward spiral is a cause for concern.
iRhythm Technologies, Inc., is a digital healthcare company specializing in long-term cardiac monitoring. The firm has solid revenues and gross margins, and its stock is up nearly 20% YTD.
IRTC is up 11% in premarket after releasing strong Q1 results. Its revenue of $158.7 million is up 20% YoY, and its adjusted loss per share has reduced to $0.95 from $1.23 in the same quarter of the previous year. The company’s full-year 2025 revenue guidance of $690 million to $700 million is also up from $675 million to $685 million earlier.
My Take: iRhythm Technologies has shown robust growth in the digital health sector, with strong revenue increases and improved margins. However, it has not yet achieved net profitability. Keep a close eye on the stock.
Exact Sciences Corporation is a molecular diagnostics company specializing in cancer detection and treatment guidance. It has seen consistent growth in revenue over the years but its net margins dropped significantly in 2024.
The stock is rising in premarket trading due to its strong Q1 results, where it reported revenues of $706.8 million, up from $637.5 million, and narrowed its adjusted net loss to $0.21 per diluted share from $0.37. For the full year 2025, it raised its revenue guidance to between $3.07 billion to $3.12 billion.
My Take: Exact Sciences continues to show strong growth in the cancer diagnostics market. However, its ability to achieve net profits is still a concern. Nevertheless, it is a good stock to keep on your radar.
On Behalf of Azincourt Energy Corp
With AI pushing power demand through the roof, nuclear is the only option.
Uranium demand is set to double. One junior may benefit most.
*Examples that we provide of share price increases pertaining to a particular Issuer from one referenced date to another represent an arbitrarily chosen time period and are no indication whatsoever of future stock prices for that Issuer and are of no predictive value. Our stock profiles are intended to highlight certain companies for YOUR further investigation; they are NOT stock recommendations or constitute an offer or sale of the referenced securities.
Tariff uncertainty and falling China revenue eclipse Apple’s stronger-than-expected earnings.
High cloud margins fail to offset slowing growth at Amazon Web Services.
Amgen backs tax incentives over tariffs amid strong earnings and a biotech expansion.
Analysts remain bullish as Stryker’s Q1 results reinforce an optimistic 2024 outlook.
MicroStrategy posts a steep quarterly loss as revenue falls below Wall Street expectations.
Airbnb’s profit shrinks but revenue climbs as travel demand holds steady.
Despite record sales and cash flow, weak Q2 guidance drags down Motorola’s stock.
That’s all for today. Thank you for reading. If you have any feedback, please reply to this email.
Best Regards,
— Adam Garcia
Elite Trade Club
Click here to get our daily newsletter straight to your cell for free.
P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.
*Standard message/carrier rates may apply.
Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website, which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside these emails.